Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Brain
    August 2022
  1. COURSE MM, Gudsnuk K, Keene CD, Bird TD, et al
    Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Brain. 2022 Aug 11. pii: 6660735. doi: 10.1093.
    >> Share

  2. LUO J, Agboola F, Grant E, Morris JC, et al
    Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan.
    Brain. 2022 Aug 4. pii: 6655799. doi: 10.1093.
    >> Share

    July 2022
  3. HUSAIN M
    Molecular pathology and biomarker of progression in Alzheimer's disease.
    Brain. 2022;145:2229-2230.
    >> Share

  4. GROOT C, Holstege H, Ossenkoppele R
    Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?
    Brain. 2022;145:2239-2241.
    >> Share

  5. CASALETTO KB, Nichols E, Aslanyan V, Simone SM, et al
    Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults.
    Brain. 2022 Jul 23. pii: 6648895. doi: 10.1093.
    >> Share

  6. LONG JM, Coble DW, Xiong C, Schindler SE, et al
    Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
    Brain. 2022 Jul 22. pii: 6648721. doi: 10.1093.
    >> Share

  7. DEWENTER A, Jacob MA, Cai M, Gesierich B, et al
    Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
    Brain. 2022 Jul 21. pii: 6647593. doi: 10.1093.
    >> Share

  8. BIESSELS GJ
    Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?
    Brain. 2022 Jul 15. pii: 6644842. doi: 10.1093.
    >> Share

  9. WANG Q, Huang X, Su Y, Yin G, et al
    Activation of Wnt/beta-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
    Brain. 2022 Jul 5. pii: 6630034. doi: 10.1093.
    >> Share

    June 2022
  10. GRAHAM NSN
    Progress towards predicting neurodegeneration and dementia after traumatic brain injury.
    Brain. 2022;145:1874-1876.
    >> Share

  11. JENKINS LM, Wang L, Rosen H, Weintraub S, et al
    A transdiagnostic review of neuroimaging studies of apathy and disinhibition in dementia.
    Brain. 2022;145:1886-1905.
    >> Share

  12. MEHRARAM R, Peraza LR, Murphy NRE, Cromarty RA, et al
    Functional and structural brain network correlates of visual hallucinations in Lewy body dementia.
    Brain. 2022;145:2190-2205.
    >> Share

  13. LEVEY AI, Qiu D, Zhao L, Hu WT, et al
    A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
    Brain. 2022;145:1924-1938.
    >> Share

  14. TANNER JA, Iaccarino L, Edwards L, Asken BM, et al
    Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
    Brain. 2022 Jun 28. pii: 6619120. doi: 10.1093.
    >> Share

  15. KAIVOLA K, Shah Z, Chia R, Scholz SW, et al
    Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
    Brain. 2022;145:1757-1762.
    >> Share

    May 2022
  16. TONIOLO S
    What plasma biomarkers tell us about hippocampal microstructural changes in Alzheimer's disease.
    Brain. 2022 May 25. pii: 6591892. doi: 10.1093.
    >> Share

  17. DUZEL E, Ziegler G, Berron D, Maass A, et al
    Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction.
    Brain. 2022;145:1473-1485.
    >> Share

  18. KO H, Kim S, Kim K, Jung SH, et al
    Genome-wide association study of occupational attainment as a proxy for cognitive reserve.
    Brain. 2022;145:1436-1448.
    >> Share

  19. MORRIS JC, Weiner M, Xiong C, Beckett L, et al
    Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology.
    Brain. 2022 May 17. pii: 6587090. doi: 10.1093.
    >> Share

  20. MORRISON MS, Aparicio HJ, Blennow K, Zetterberg H, et al
    Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Brain. 2022 May 13. pii: 6585495. doi: 10.1093.
    >> Share


  21. Correction to: Brain amyloid-beta oligomers in ageing and Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585189. doi: 10.1093.
    >> Share

  22. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    >> Share

  23. ZHU WM, Neuhaus A, Beard DJ, Sutherland BA, et al
    Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585171. doi: 10.1093.
    >> Share

  24. VROMEN EM, de Boer SCM, Teunissen CE, Rozemuller A, et al
    Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
    Brain. 2022 May 2. pii: 6576655. doi: 10.1093.
    >> Share

    April 2022
  25. BARKER MS, Gottesman RT, Manoochehri M, Chapman S, et al
    Proposed research criteria for prodromal behavioural variant frontotemporal dementia.
    Brain. 2022;145:1079-1097.
    >> Share

  26. LEGAZ A, Abrevaya S, Dottori M, Gonzalez Campo C, et al
    Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases.
    Brain. 2022;145:1052-1068.
    >> Share

  27. MESULAM MM, Coventry CA, Bigio EH, Sridhar J, et al
    Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Brain. 2022 Apr 20. pii: 6570516. doi: 10.1093.
    >> Share

  28. SHAHID SS, Wen Q, Risacher SL, Farlow MR, et al
    Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
    Brain. 2022 Apr 12. pii: 6566798. doi: 10.1093.
    >> Share

  29. OLIVEROS G, Wallace CH, Chaudry O, Liu Q, et al
    Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
    Brain. 2022 Apr 12. pii: 6566790. doi: 10.1093.
    >> Share

  30. STEVENSON-HOARE J, Heslegrave A, Leonenko G, Fathalla D, et al
    Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
    Brain. 2022 Apr 6. pii: 6564132. doi: 10.1093.
    >> Share

  31. PADHI S, Sarangi S, Nayak N, Pati A, et al
    OAS1 rs1131454 genetic variant is associated with Alzheimer's disease: an epidemiological analysis.
    Brain. 2022 Apr 6. pii: 6564066. doi: 10.1093.
    >> Share

    March 2022
  32. JEONG YY, Han S, Jia N, Zhang M, et al
    Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.
    Brain. 2022;145:305-323.
    >> Share

  33. BENATAR M, Wuu J, McHutchison C, Postuma RB, et al
    Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Brain. 2022;145:27-44.
    >> Share

  34. HOSOKAWA M, Masuda-Suzukake M, Shitara H, Shimozawa A, et al
    Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Brain. 2022;145:349-361.
    >> Share

  35. GIACOBINI E, Cuello AC, Fisher A
    Reimagining cholinergic therapy for Alzheimer's disease.
    Brain. 2022 Mar 15. pii: 6548684. doi: 10.1093.
    >> Share

  36. SHETTY AK
    Can rapamycin slow down memory decline in Alzheimer's disease with seizures?
    Brain. 2022 Mar 12. pii: 6547363. doi: 10.1093.
    >> Share

  37. LAM AD, Shafi MM
    Towards a coherent view of network hyperexcitability in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6544859. doi: 10.1093.
    >> Share

  38. LIN CP, Frigerio I, Boon BDC, Zhou Z, et al
    Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
    Brain. 2022 Mar 8. pii: 6543231. doi: 10.1093.
    >> Share

  39. GABRIELLI M, Prada I, Joshi P, Falcicchia C, et al
    Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease.
    Brain. 2022 Mar 3. pii: 6541881. doi: 10.1093.
    >> Share

    February 2022
  40. BEAMAN EE, Bonde AN, Ulv Larsen SM, Ozenne B, et al
    Blood-brain barrier permeable beta-blockers linked to lower risk of Alzheimer's disease in hypertension.
    Brain. 2022 Feb 23. pii: 6535129. doi: 10.1093.
    >> Share

  41. PERIS L, Parato J, Qu X, Soleilhac JM, et al
    Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer's disease.
    Brain. 2022 Feb 11. pii: 6527175. doi: 10.1093.
    >> Share

    January 2022
  42. KARANTH SD, Katsumata Y, Nelson PT, Fardo DW, et al
    Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Brain. 2022 Jan 30. pii: 6517521. doi: 10.1093.
    >> Share

  43. WIESMAN AI, Murman DL, Losh RA, Schantell M, et al
    Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.
    Brain. 2022 Jan 28. pii: 6516524. doi: 10.1093.
    >> Share

  44. MARTINO ADAMI PV, Orellana A, Garcia P, Kleineidam L, et al
    Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
    Brain. 2022 Jan 28. pii: 6516341. doi: 10.1093.
    >> Share

  45. STERN AM, Liu L, Jin S, Liu W, et al
    A calcium-sensitive antibody isolates soluble amyloid-beta aggregates and fibrils from Alzheimer's disease brain.
    Brain. 2022 Jan 27. pii: 6516009. doi: 10.1093.
    >> Share

  46. ALI M, Falkenhain K, Njiru BN, Murtaza-Ali M, et al
    VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice.
    Brain. 2022 Jan 20. pii: 6512043. doi: 10.1093.
    >> Share

  47. BRIDEL C, Somers C, Sieben A, Rozemuller A, et al
    Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.
    Brain. 2022 Jan 13. pii: 6506576. doi: 10.1093.
    >> Share

    December 2021
  48. RANASINGHE KG, Kudo K, Hinkley L, Beagle A, et al
    Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early onset Alzheimer's disease.
    Brain. 2021 Dec 17. pii: 6469013. doi: 10.1093.
    >> Share

  49. XHIMA K, Markham-Coultes K, Kofoed RH, Saragovi HU, et al
    Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies.
    Brain. 2021 Dec 17. pii: 6469023. doi: 10.1093.
    >> Share

  50. TSAI HH, Chen YF, Yen RF, Lo YL, et al
    Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Brain. 2021;144:3371-3380.
    >> Share

  51. PASCOAL TA, Benedet AL, Tudorascu DL, Therriault J, et al
    Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Brain. 2021;144:3517-3528.
    >> Share

  52. ABRAHAMSON EE, Kofler JK, Becker CR, Price JC, et al
    11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous.
    Brain. 2021 Dec 16. pii: 6464340. doi: 10.1093.
    >> Share

    November 2021
  53. VERDI S, Marquand AF, Schott JM, Cole JH, et al
    Beyond the average patient: how neuroimaging models can address heterogeneity in dementia.
    Brain. 2021;144:2946-2953.
    >> Share

    October 2021
  54. ZHANG Y, Zhang Y, Aman Y, Ng CT, et al
    Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
    Brain. 2021;144:2759-2770.
    >> Share

  55. LUCEY BP, Wisch J, Boerwinkle AH, Landsness EC, et al
    Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease.
    Brain. 2021 Oct 20. pii: 6401973. doi: 10.1093.
    >> Share

  56. LEVY JP, Bezgin G, Savard M, Pascoal TA, et al
    18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Brain. 2021 Oct 19. pii: 6402002. doi: 10.1093.
    >> Share

  57. MAGUSALI N, Graham AC, Piers TM, Panichnantakul P, et al
    A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
    Brain. 2021 Oct 7. pii: 6382473. doi: 10.1093.
    >> Share

  58. KHAN AF, Adewale Q, Baumeister TR, Carbonell F, et al
    Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380944. doi: 10.1093.
    >> Share

  59. SCHUMACHER J, Ray NJ, Hamilton CA, Donaghy PC, et al
    Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Brain. 2021 Oct 4. pii: 6380941. doi: 10.1093.
    >> Share

    September 2021

  60. Erratum to: Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Sep 22. pii: 6373794. doi: 10.1093.
    >> Share

  61. STOTHART G, Smith LJ, Milton A, Coulthard E, et al
    A passive and objective measure of recognition memory in Alzheimer's disease using Fastball memory assessment.
    Brain. 2021 Sep 20. pii: 6372384. doi: 10.1093.
    >> Share

    August 2021
  62. KHAN AR, Ottoy J, Goubran M
    Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
    Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
    >> Share

  63. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
    Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
    >> Share

  64. BOYLE PA, Wang T, Yu L, Wilson RS, et al
    To what degree is late life cognitive decline driven by age-related neuropathologies?
    Brain. 2021;144:2166-2175.
    >> Share

  65. HOLLAND N, Malpetti M, Rittman T, Mak EE, et al
    Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Brain. 2021 Aug 16. pii: 6353021. doi: 10.1093.
    >> Share

  66. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    >> Share

    July 2021
  67. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
    Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
    >> Share

  68. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
    The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
    Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
    >> Share

  69. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
    >> Share

  70. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    >> Share

  71. BAILES SM, Lewis LD
    Distinct cardiac-locked brain pulsations in Alzheimer's disease.
    Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
    >> Share

  72. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2021 Jul 3. pii: 6313379. doi: 10.1093.
    >> Share

    June 2021
  73. RIES M, Watts H, Mota BC, Lopez MY, et al
    Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-beta and tau pathology.
    Brain. 2021;144:1526-1541.
    >> Share

  74. MATTHEWS DC, Mao X, Dowd K, Tsakanikas D, et al
    Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Brain. 2021 Jun 18. pii: 6305835. doi: 10.1093.
    >> Share

  75. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
    >> Share

  76. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    >> Share

    May 2021

  77. Erratum to: The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2021 May 23. pii: 6282423. doi: 10.1093.
    >> Share

  78. DEHGHANI N, Bras J, Guerreiro R
    Erratum to: How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 May 20. pii: 6279241. doi: 10.1093.
    >> Share

    April 2021
  79. O'CONNOR A, Pannee J, Poole T, Arber C, et al
    Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
    Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
    >> Share

  80. DEHGHANI N, Bras J, Guerreiro R
    How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
    >> Share

  81. YAO Y, Kang SS, Xia Y, Wang ZH, et al
    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
    Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
    >> Share


  82. Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
    >> Share

  83. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
    Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
    Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
    >> Share

  84. TOME SO, Thal DR
    Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Brain. 2021;144:706-708.
    >> Share


  85. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    >> Share

    March 2021
  86. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
    Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
    >> Share

  87. YAP SY, Frias B, Wren MC, Scholl M, et al
    Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
    >> Share

  88. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    >> Share

  89. ASBY D, Boche D, Allan S, Love S, et al
    Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6173392. doi: 10.1093.
    >> Share

  90. SPINA S, La Joie R, Petersen C, Nolan AL, et al
    Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
    Brain. 2021 Mar 9. pii: 6164966. doi: 10.1093.
    >> Share

  91. HUSAIN M
    Blood tests to screen for Alzheimer's disease.
    Brain. 2021;144:355-356.
    >> Share

  92. KIM JH, Afridi R, Han J, Jung HG, et al
    Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Brain. 2021;144:528-552.
    >> Share

    February 2021
  93. JAGUST W
    Integrating events in the disintegration of Alzheimer's disease.
    Brain. 2021;144:11-14.
    >> Share

  94. TIJMS BM, Teunissen CE
    Concatenating plasma p-tau to Alzheimer's disease.
    Brain. 2021;144:14-17.
    >> Share

    January 2021
  95. KESHAVAN A, Pannee J, Karikari TK, Rodriguez JL, et al
    Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
    Brain. 2021 Jan 22. pii: 6105867. doi: 10.1093.
    >> Share


  96. Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2021 Jan 12. pii: 6091150. doi: 10.1093.
    >> Share

    December 2020
  97. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
    Hearing and dementia: from ears to brain.
    Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
    >> Share

  98. MONTERO-CRESPO M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, et al
    Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
    Brain. 2020 Dec 16. pii: 6038920. doi: 10.1093.
    >> Share

  99. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2020 Dec 7. pii: 6024973. doi: 10.1093.
    >> Share

  100. TEUNISSEN CE, Thijssen EH, Verberk IMW
    Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
    Brain. 2020;143:3170-3172.
    >> Share

  101. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    >> Share

  102. TIJMS BM, Gobom J, Reus L, Jansen I, et al
    Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Brain. 2020;143:3776-3792.
    >> Share

  103. SMITH R, Strandberg O, Mattsson-Carlgren N, Leuzy A, et al
    The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Brain. 2020;143:3805-3815.
    >> Share

  104. FLORES-AGUILAR L, Iulita MF, Kovecses O, Torres MD, et al
    Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Brain. 2020;143:3653-3671.
    >> Share

    November 2020
  105. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    >> Share

  106. BRIER MR, Day GS
    Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
    Brain. 2020 Nov 30. pii: 6012788. doi: 10.1093.
    >> Share

  107. SUR C, Kost J, Scott D, Adamczuk K, et al
    BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
    Brain. 2020 Nov 30. pii: 6012787. doi: 10.1093.
    >> Share

  108. RUAN Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, et al
    Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2020 Nov 27. pii: 6007752. doi: 10.1093.
    >> Share

  109. BENEDET AL, Leuzy A, Pascoal TA, Ashton NJ, et al
    Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Brain. 2020 Nov 19. pii: 5990278. doi: 10.1093.
    >> Share

  110. JIA L, Li F, Wei C, Zhu M, et al
    Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Brain. 2020 Nov 14. pii: 5981992. doi: 10.1093.
    >> Share

  111. LIU KY, Reeves S, McAleese KE, Attems J, et al
    Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Brain. 2020 Nov 14. pii: 5981742. doi: 10.1093.
    >> Share

  112. JI X, Liu G
    rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974904. doi: 10.1093.
    >> Share

  113. DUMITRESCU L, Hohman TJ
    Reply: rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974883. doi: 10.1093.
    >> Share

  114. JOSEPHS KA, Martin PR, Weigand SD, Tosakulwong N, et al
    Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Brain. 2020 Nov 5. pii: 5956321. doi: 10.1093.
    >> Share

  115. SOLEIMANI-MEIGOONI DN, Iaccarino L, La Joie R, Baker S, et al
    18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Brain. 2020 Nov 3. pii: 5952719. doi: 10.1093.
    >> Share

    October 2020
  116. MATTSSON-CARLGREN N, Janelidze S, Palmqvist S, Cullen N, et al
    Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Brain. 2020 Oct 17. pii: 5929275. doi: 10.1093.
    >> Share

    September 2020
  117. FORSBERG MOREN A, Varrone A
    Timing is everything: tau imaging across stages of Alzheimer's disease.
    Brain. 2020;143:2634-2636.
    >> Share

  118. HARDY CJD, Yong KXX, Goll JC, Crutch SJ, et al
    Impairments of auditory scene analysis in posterior cortical atrophy.
    Brain. 2020 Sep 1. pii: 5900355. doi: 10.1093.
    >> Share

    August 2020
  119. HORSAGER J, Andersen KB, Knudsen K, Skjaerbaek C, et al
    Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
    Brain. 2020 Aug 24. pii: 5896254. doi: 10.1093.
    >> Share

  120. DRUMMOND E, Pires G, MacMurray C, Askenazi M, et al
    Phosphorylated tau interactome in the human Alzheimer's disease brain.
    Brain. 2020 Aug 19. pii: 5893817. doi: 10.1093.
    >> Share

  121. DUMITRESCU L, Mahoney ER, Mukherjee S, Lee ML, et al
    Genetic variants and functional pathways associated with resilience to Alzheimer's disease.
    Brain. 2020;143:2561-2575.
    >> Share

    July 2020
  122. HARRISON IF, Ismail O, Machhada A, Colgan N, et al
    Impaired glymphatic function and clearance of tau in an Alzheimer's disease model.
    Brain. 2020 Jul 23. pii: 5875735. doi: 10.1093.
    >> Share

  123. PASCOAL TA, Therriault J, Benedet AL, Savard M, et al
    18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Brain. 2020 Jul 16. pii: 5872095. doi: 10.1093.
    >> Share

  124. COUSINS KAQ, Irwin DJ, Wolk DA, Lee EB, et al
    ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration.
    Brain. 2020;143:2295-2311.
    >> Share

    June 2020
  125. FAN CC, Banks SJ, Thompson WK, Chen CH, et al
    Sex-dependent autosomal effects on clinical progression of Alzheimer's disease.
    Brain. 2020 Jun 27. pii: 5863662. doi: 10.1093.
    >> Share

  126. SINTINI I, Graff-Radford J, Senjem ML, Schwarz CG, et al
    Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Brain. 2020 Jun 23. pii: 5861030. doi: 10.1093.
    >> Share

  127. PRZYBYLA M, van Eersel J, van Hummel A, van der Hoven J, et al
    Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Brain. 2020;143:1889-1904.
    >> Share

    May 2020
  128. ARENA JD, Smith DH, Lee EB, Gibbons GS, et al
    Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.
    Brain. 2020 May 11. pii: 5835545. doi: 10.1093.
    >> Share

  129. MALPETTI M, Kievit RA, Passamonti L, Jones PS, et al
    Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Brain. 2020 May 7. pii: 5831943. doi: 10.1093.
    >> Share

  130. QIU S, Joshi PS, Miller MI, Xue C, et al
    Development and validation of an interpretable deep learning framework for Alzheimer's disease classification.
    Brain. 2020 May 1. pii: 5827821. doi: 10.1093.
    >> Share

    April 2020
  131. SPOTORNO N, Acosta-Cabronero J, Stomrud E, Lampinen B, et al
    Relationship between cortical iron and tau aggregation in Alzheimer's disease.
    Brain. 2020 Apr 24. pii: 5824902. doi: 10.1093.
    >> Share

  132. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2020 Apr 6. pii: 5816707. doi: 10.1093.
    >> Share

  133. VELDSMAN M
    Atrophy network mapping of transdiagnostic cognitive and neuropsychiatric symptoms.
    Brain. 2020;143:1053-1056.
    >> Share

  134. DE WOLF F, Ghanbari M, Licher S, McRae-McKee K, et al
    Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study.
    Brain. 2020;143:1220-1232.
    >> Share

    March 2020
  135. TETREAULT AM, Phan T, Orlando D, Lyu I, et al
    Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease.
    Brain. 2020 Mar 16. pii: 5807900. doi: 10.1093.
    >> Share

  136. FERNANDEZ-CABELLO S, Kronbichler M, Van Dijk KRA, Goodman JA, et al
    Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
    Brain. 2020;143:993-1009.
    >> Share

  137. AGOSTA F, Canu E, Filippi M
    Virtual reality and real-time neurofeedback functional MRI: a breakthrough in foreseeing Alzheimer's disease?
    Brain. 2020;143:722-726.
    >> Share

  138. SKOURAS S, Torner J, Andersson P, Koush Y, et al
    Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
    Brain. 2020;143:976-992.
    >> Share

    February 2020
  139. NELSON PT
    Reply: Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.
    Brain. 2020 Feb 4. pii: 5722221. doi: 10.1093.
    >> Share

  140. TORRES P, Andres-Benito P, Fernandez-Bernal A, Ricart M, et al
    Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.
    Brain. 2020 Feb 4. pii: 5722222. doi: 10.1093.
    >> Share

  141. PICHET BINETTE A, Gonneaud J, Vogel JW, La Joie R, et al
    Morphometric network differences in ageing versus Alzheimer's disease dementia.
    Brain. 2020;143:635-649.
    >> Share

  142. ITURRIA-MEDINA Y, Khan AF, Adewale Q, Shirazi AH, et al
    Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration.
    Brain. 2020;143:661-673.
    >> Share

  143. TEYLAN M, Mock C, Gauthreaux K, Chen YC, et al
    Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Brain. 2020;143:611-621.
    >> Share

    January 2020
  144. ROBINSON JL, Richardson H, Xie SX, Suh E, et al
    The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2020 Jan 15. pii: 6101614. doi: 10.1093.
    >> Share

  145. BETTHAUSER TJ, Koscik RL, Jonaitis EM, Allison SL, et al
    Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
    Brain. 2020;143:320-335.
    >> Share

  146. ROWE J
    Editorial.
    Brain. 2020;143:1.
    >> Share

    December 2019
  147. BADHWAR A, McFall GP, Sapkota S, Black SE, et al
    A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
    Brain. 2019 Dec 31. pii: 5692271. doi: 10.1093.
    >> Share

  148. GOURMAUD S, Shou H, Irwin DJ, Sansalone K, et al
    Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
    Brain. 2019 Dec 13. pii: 5675543. doi: 10.1093.
    >> Share

  149. BLENNOW K, Chen C, Cicognola C, Wildsmith KR, et al
    Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
    Brain. 2019 Dec 13. pii: 5675540. doi: 10.1093.
    >> Share

  150. KORONYO-HAMAOUI M, Sheyn J, Hayden EY, Li S, et al
    Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
    Brain. 2019 Dec 3. pii: 5651064. doi: 10.1093.
    >> Share

    November 2019
  151. MORRONE CD, Bazzigaluppi P, Beckett TL, Hill ME, et al
    Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-beta attenuation.
    Brain. 2019 Nov 28. pii: 5647334. doi: 10.1093.
    >> Share

  152. YOUNAN D, Petkus AJ, Widaman KF, Wang X, et al
    Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
    Brain. 2019 Nov 20. pii: 5628036. doi: 10.1093.
    >> Share

    October 2019
  153. LIU G, Zhang H, Liu B, Ji X, et al
    Rs2293871 regulates HTRA1 expression and affects cerebral small vessel stroke and Alzheimer's disease.
    Brain. 2019 Oct 11. pii: 5585665. doi: 10.1093.
    >> Share

  154. ZHANG M, Dilliott AA, Khallaf R, Robinson JF, et al
    Genetic and epigenetic study of an Alzheimer's disease family with monozygotic triplets.
    Brain. 2019 Oct 3. pii: 5580538. doi: 10.1093.
    >> Share

    September 2019
  155. TAKAHATA K, Kimura Y, Sahara N, Koga S, et al
    PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury.
    Brain. 2019 Sep 2. pii: 5556830. doi: 10.1093.
    >> Share

    June 2019
  156. JEGANATHAN J, Breakspear M
    Are the 'atoms of thought' longer in Lewy body dementia?
    Brain. 2019;142:1494-1497.
    >> Share

  157. HOWETT D, Castegnaro A, Krzywicka K, Hagman J, et al
    Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation.
    Brain. 2019;142:1751-1766.
    >> Share

  158. NELSON PT, Dickson DW, Trojanowski JQ, Jack CR, et al
    Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
    Brain. 2019;142:1503-1527.
    >> Share

  159. ALBERT M, Mairet-Coello G, Danis C, Lieger S, et al
    Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Brain. 2019;142:1736-1750.
    >> Share

  160. SCHUMACHER J, Peraza LR, Firbank M, Thomas AJ, et al
    Dysfunctional brain dynamics and their origin in Lewy body dementia.
    Brain. 2019;142:1767-1782.
    >> Share

    April 2019
  161. ILLAN-GALA I, Montal V, Borrego-Ecija S, Vilaplana E, et al
    Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.
    Brain. 2019;142:1121-1133.
    >> Share

  162. KNOPMAN DS, Lundt ES, Therneau TM, Vemuri P, et al
    Entorhinal cortex tau, amyloid-beta, cortical thickness and memory performance in non-demented subjects.
    Brain. 2019;142:1148-1160.
    >> Share

    January 2019
  163. POWER MC
    Growing evidence links air pollution exposure to risk of Alzheimer's disease and related dementia.
    Brain. 2019;143:8-10.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016